and McConahey, 1963; Becker, Titus, Woolner, and Ferguson, 1963; Kornstad and Kornstad. 1964) but not all (Hijmans, Doniach, Roitt, and Holborow, 1961;  Masi, Hartmann, Hahn, Abbey, and Shulman, 1965; Mulhern, Masi, and Shulman, 1966) have noted an increased prevalence of organ-specific thyroid autoantibodies and chronic thyroiditis in patients with RA. The position regarding the prevalence of gastric parietal-cell autoantibodies in RA is not clear, although Roitt, Doniach, and Shapland (1965) have noted that the "incidence is only slightly raised above that of controls".
The first purpose of this study was to define the prevalence of gastric parietal-c-ll autoantibody in patients with R', and to compare this with the prevalence found in patients with other forms of arthritis, such as osteo-arthritis, Reiter's disease, psoriatic arthritis, ankylosing spondylitis, and gout. The second purpose of the study was to determine whether the gastric parietal-cell autoantibody found in some patients with RA resulted from a non-organspecific autoantibody which stained the cytoplasm of gastric parietal cells, or whether it was organspecific as in pernicious anaemia (Irvine, Davies, Delamore, and Wynn Williams, 1962; Markson and Moore, 1962; Taylor, Roitt, Doniach, Couchman, and Shapland, 1962; Irvine 1965) and iron deficiency anaemia (Markson and Moore, 1962; Dagg, Goldberg, Anderson, Beck, and Gray, 1964) and associated with chronic atrophic gastritis.
Material and Methods Patients Studied
Gastric parietal-cell autoantibody was studied in the sera of 325 patients with "probable", "definite", and "classical" RA as defined by the American Rheumatism Association criteria (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) and in the sera of 231 patients with osteoarthritis, fifteen with Reiter's disease, fourteen with psoriatic arthritis, twelve with gout, and three with ankylosing spondylitis. The age and sex distribution of these patients is shown in Table I (overleaf).
Immunofluorescence
The gastric parietal-cell autoantibody was studied by an immunofluorescent sandwich technique described by Adams, Glen, Kennedy, Mackenzie, Morrow, Anderson, Gray, and Middleton (1964) . The serum was tested undiluted against 5jt. cryostat sections of the body of fresh human stomach obtained at operation for peptic ulcer. Sections were randomly dispersed within large batches of routine slides in the immunopathology laboratory and read by the author and by another two experienced, independent observers. Only stronglypositive staining was considered indicative of the presence of the autoantibody. (Heller, Jacobson, Kolodny, and Kammerer, 1954) , antinuclear factor (ANF) tests (Beck, 1961) , serum globulin levels, and haemoglobin concentrations. The control patients with negative tests for gastric parietal-cell autoantibodies had significantly lower serum albumin levels (t= 3 -175; P < 0 01) and significantly higher erythrocyte sedimentation-rates (t = 2 205; P < 0 05). The two groups were comparable with regard to drug therapy (Table III) . although significantly more of the patients with gastric parietal-cell autoantibody in their serum had received phenylbutazone therapy in the past (X2 = 6-527; P< 0-01).
Gastric Function Tests
Augmented histamine test meals (Kay, 1953) were carried out by the following technique.
After an overnight fast, a No. 16 gauge radio-opaque tube (Neoplex, Rayx, Porges, France) was passed per nasam into the stomach. The patient was placed comfortably on the left side and the tube manoeuvred while hand suction was applied until the position of maximum drainage was ascertained. The tube was then fixed in position and continuous suction of 5-10 mm. Hg was applied using a continuous suction pump.* The position of the tube was confirmed radiologically in two patients in the test group (Cases 2 and 12) and two controls (Cases 3 and 4). The tubes were checked regularly during the test to ensure patency.
After the gastric tube had been passed the stomach contents were aspirated for 30 minutes and discarded. (Kay, 1953) .
The pH of both gastric juice specimens was measured using a glass electrode, and 10 ml. aliquots of the aspirates were titrated against standard N/10 NaOH using Topffer's reagent and Phenol red as indicators, thus giving a measure of free and total acidity. The free acid is hydrochloric acid and the total acid includes the contribution by acid mucoprotein residues and organic acids. The maximal free acid secretion has been shown to correlate with total parietal-cell mass both in human beings (Card and Marks, 1960) and in dogs (Marks, Komarov, and Shay, 1960) .
Statistical Methods
Data were analysed either by a standard Student's "t" test or by a x2 analysis. Where small numbers were involved in the x2 analysis, Yates's correction for continuity was employed. Table I shows that the prevalence of positive tests for gastric parietal-cell autoantibody in female patients with "probable", "definite", and "clas- 3-6+0-6 27-2+24-7 13 0+1*4 (7)
Results

Prevalence of Gastric Parietal-celi Autoantibody in Arthritic Patients
(1 1) (11) (10) (IP) Table IV . Eleven of the twelve positive patients had no detectable free or total acid in the basal specimen, whereas only six of the fourteen controls had achlorhydria in the basal specimen. These differences are, however, not significant. The differences between the two groups are more marked in the post-histamine specimens. If histamine-fast hypochlorhydria is defined as < 2 0 mEq/hr of maximal free acid secretion in the post-histamine hour, then it can be seen that nine of the twelve positive patients and only two of the fourteen controls had hypochlorhydria. These differences are significant (X2 = 7 429; P < 0 05). No correlation was found between any current or past drug therapy, in particular oral analgesics and the results of the augmented histamine test, but the numbers involved in the two groups, are, of course, too small to allow any concrete statistical analysis of this point. 
Discussion
Although there is some evidence for an increased prevalence of organ-specific thyroid autoantibodies and chronic thyroiditis in patients with RA, the present study has shown no evidence of an increased prevalence of gastric parietal-cell autoantibodies (Table I ). These observations are consistent with those of Roitt and others (1965) , who also found no significant increase in prevalence of gastric parietalcell autoantibody. It is of interest, however, that an increase prevalence of gastric parietal-cell autoantibodies has been observed in Glasgow in female patients with Sj6gren's syndrome (Goudie and Buchanan, 1967) , although no increased prevalence was noted in the serum of patients with Sj6gren's syndrome diagnosed by the same criteria at the National Institutes of Health, Bethesda, Maryland, U.S.A., when tested in the same laboratory in Glasgow (Anderson, Beck, Bloch, Buchanan, and Bunim, 1965) .
Gastric parietal-cell autoantibody is found in the serum of over 80 per cent. of patients with pernicious anaemia (Irvine and others, 1962; Taylor and others, 1962; Bernhardt, Burkett, Fields, and Killian, 1965; De Boer, Nairn, and Maxwell, 1965) and is also commonly found in the serum of patients suffering from a variety of other autoimmune diseases, such as autoimmune thyroiditis (Doniach, Roitt, and Taylor, 1963; Irvine, 1966) , thyrotoxicosis (Doniach and others, 1963) , and iron deficiency anaemia (Markson and Moore, 1962; Dagg and others, 1964) , as well as in miscellaneous conditions such as diabetes mellitus (Moore and Neilson, 1963) , and in a proportion of apparently healthy people. Where the autoantibody is present in the absence of pernicious anaemia, gastric mucosal biopsy invariably reveals chronic atrophic gastritis associated with varying degrees of impairment of gastric secretion following maximal histamine stimulation (Irvine, 1965; Adams and others, 1964; Irvine, Davies, Teitelbaum, Delamore, and Wynn Williams, 1965; Coghill, Doniach, Roitt, Mollin, and Wynn Williams 1965; Williams, Scott, Beck, and Blair, 1966) .
In twelve positive patients who had no non-organ specific autoantibody demonstrable by testing against rat kidney and human thyroid (Roitt and others, 1965) , a significant impairment of gastric acid secretion as detected by the augmented histamine test meal (Kay, 1953) was demonstrated as compared with fourteen controls matched for age and sex. (The fact that the control patients were in a more active phase of the disease as shown by hypoalbuminaemia and raised erythrocyte sedimentation rate was not considered to have influenced the results of the augmented histamine test meals.) This presumably reflects chronic atrophic gastritis in these patients with gastric parietal-cell autoantibodies, since there is evidence that the degree of hypochlorhydria is related to the viable parietal-cell mass and to the extent of chronic atrophic gastritis (Card and Marks, 1960; Marks and others, 1960; Irvine, 1966) . It was not felt justified to submit these patients to the inconvenience and potential hazard of gastric mucosal biopsy to prove this point completely.
The oral analgesic and corticosteroid drugs used in the treatment of RA are known to influence gastric function (Kirsner and Ford, 1955; Mauer, 1955; Weiss, Pitman, and Graham, 1961; Scott, Porter, Lewis, and Dixon, 1961; Ballabio, Cirla, Girardi, Caruso, and Colombo, 1963; Rothermich, 1966) , but in the present study there was no correlation between the past or present administration of any one drug and the results of the augmented histamine test meals, although the numbers involved preclude any statistical analysis of this point.
GASTRIC PARIETAL-CELL A UTOANTIBOD Y
It is concluded that there is no increased prevalance of gastric parietal-cell autoantibodies in RA patients, but that when such autoantibodies are found they are organ-specific and are related to chronic atrophic gastritis with impairment of gastric acid secretory function. Further studies would be of interest to determine the relationship of gastric parietal-cell autoantibodies to latent pernicious anaemia in patients suffering from RA.
Summary
The prevalence of gastric parietal-cell autoantibody was studied in patients with rheumatoid arthritis, using an immunofluorescent sandwich technique, and was found to be similar to that in osteo-arthritic controls matched for age and sex. The prevalance in various other forms of arthritis was also found to be low.
Twelve patients with rheumatoid arthritis and positive tests for gastric parietal-cell autoantibody were selected for further study. The gastric parietalcell autoantibody was shown in these patients to be organ-specific by exclusion of sera containing nonspecific autoantibody demonstrable by testing against rat kidney and human thyroid gland. Augmented histamine test meals in these patients showed significant impairment of gastric acid secretion as compared with fourteen age-and sex-matched controls with rheumatoid arthritis and negative tests for gastric parietal-cell autoantibody. No correlation was found between gastric secretory function and past or present drug therapy.
It is concluded that there is no increased prevalance of gastric parietal-cell autoantibodies in rheumatoid arthritis, but that when this autoantibody is present it is organ-specific and reflects chronic atrophic gastritis with histamine-fast hypochlorhydria. On conclut que la frequence d'autoanticorps antimuqueuse gastrique n'est pas augmentee dans l'arthrite rhumatismale, mais quand ces autoanticorps existent, ils sont specifiques de l'organe et presentent une manifestation d'une gastrite atrophique chronique avec hypochlorhydrie resistante A l'histamine. Una investigaci6n de la frecuencia y del significado de los autoanticuerpos contra la mucosa gastrica en la artritis reumatoide SUMARIO Se estudio la incidencia del autoanticuerpo contra la mucosa gastrica en enfermos con artritis reumatoide, empleando el procedimiento de inmunofluorescencia "en sandwich"; los resultados hallados fueron similares a los obtenidos en testigos osteoartr6sicos, con tener cuenta de la edad y del sexo. La incidencia en varias otras formas de artritis fue tambien baja.
Se escogieron para una investigacion ulterior doce enfermos con artritis reumatoide y con auto anticuerpos contra la mucosa gastrica comprobados. Se demostr6 en estos enfermos que los autoanticuerpos contra la mucosa gastrica fueron especfficos del 6rgano por exclusi6n de los sueros con autoanticuerpos no especificos, identificados por reacciones contra el rifion de rata y la glandula tiroidea humana. Pruebas de la histamina evidenciaron en estos enfermos una inhibicion significativa de la secreci6n gastrica acida en comparaci6n con 14 testigos de edad y de sexo comparables, afectos de artritis reumatoide sin autoanticuerpo contra la mucosa gastrica. No se hallo correlacion alguna entre la funcion secretoria gastrica y la terapeutica medicamentosa pasada o presente.
Se concluye que la incidencia de autoanticuerpos contra la mucosa gastrica no se ve aumentada en la artritis reumatoide, pero los autoanticuerpos que existen son especfficos del organo y reflejan una gastritis atr6fica cronica con hipoclorhidria resistente a la histamina. 
